231 related articles for article (PubMed ID: 23669332)
1. Xanthohumol, a main prenylated chalcone from hops, reduces liver damage and modulates oxidative reaction and apoptosis in hepatitis C virus infected Tupaia belangeri.
Yang M; Li N; Li F; Zhu Q; Liu X; Han Q; Wang Y; Chen Y; Zeng X; Lv Y; Zhang P; Yang C; Liu Z
Int Immunopharmacol; 2013 Aug; 16(4):466-74. PubMed ID: 23669332
[TBL] [Abstract][Full Text] [Related]
2. Oxidative Stress and Immune Responses During Hepatitis C Virus Infection in Tupaia belangeri.
Kayesh MEH; Ezzikouri S; Sanada T; Chi H; Hayashi Y; Rebbani K; Kitab B; Matsuu A; Miyoshi N; Hishima T; Kohara M; Tsukiyama-Kohara K
Sci Rep; 2017 Aug; 7(1):9848. PubMed ID: 28852124
[TBL] [Abstract][Full Text] [Related]
3. Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis.
Dorn C; Kraus B; Motyl M; Weiss TS; Gehrig M; Schölmerich J; Heilmann J; Hellerbrand C
Mol Nutr Food Res; 2010 Jul; 54 Suppl 2():S205-13. PubMed ID: 20087858
[TBL] [Abstract][Full Text] [Related]
4. Xanthohumol, a prenylated chalcone from hops, modulates hepatic expression of genes involved in thyroid hormone distribution and metabolism.
Radović B; Hussong R; Gerhäuser C; Meinl W; Frank N; Becker H; Köhrle J
Mol Nutr Food Res; 2010 Jul; 54 Suppl 2():S225-35. PubMed ID: 20461738
[TBL] [Abstract][Full Text] [Related]
5. Xanthohumol enhances antiviral effect of interferon alpha-2b against bovine viral diarrhea virus, a surrogate of hepatitis C virus.
Zhang N; Liu Z; Han Q; Chen J; Lv Y
Phytomedicine; 2010 Apr; 17(5):310-6. PubMed ID: 19748253
[TBL] [Abstract][Full Text] [Related]
6. Xanthohumol and related prenylated flavonoids inhibit inflammatory cytokine production in LPS-activated THP-1 monocytes: structure-activity relationships and in silico binding to myeloid differentiation protein-2 (MD-2).
Peluso MR; Miranda CL; Hobbs DJ; Proteau RR; Stevens JF
Planta Med; 2010 Oct; 76(14):1536-43. PubMed ID: 20309792
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer.
Jiang W; Zhao S; Xu L; Lu Y; Lu Z; Chen C; Ni J; Wan R; Yang L
Biomed Pharmacother; 2015 Jul; 73():40-7. PubMed ID: 26211581
[TBL] [Abstract][Full Text] [Related]
8. Xanthohumol, a prenylated chalcone from beer hops, acts as an α-glucosidase inhibitor in vitro.
Liu M; Yin H; Liu G; Dong J; Qian Z; Miao J
J Agric Food Chem; 2014 Jun; 62(24):5548-54. PubMed ID: 24897556
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of hepatitis C virus infection in Tupaia belangeri.
Amako Y; Tsukiyama-Kohara K; Katsume A; Hirata Y; Sekiguchi S; Tobita Y; Hayashi Y; Hishima T; Funata N; Yonekawa H; Kohara M
J Virol; 2010 Jan; 84(1):303-11. PubMed ID: 19846521
[TBL] [Abstract][Full Text] [Related]
10. Xanthohumol-induced transient superoxide anion radical formation triggers cancer cells into apoptosis via a mitochondria-mediated mechanism.
Strathmann J; Klimo K; Sauer SW; Okun JG; Prehn JH; Gerhäuser C
FASEB J; 2010 Aug; 24(8):2938-50. PubMed ID: 20335224
[TBL] [Abstract][Full Text] [Related]
11. Recent patents on therapeutic activities of xanthohumol: a prenylated chalconoid from hops (
Aggarwal D; Upadhyay SK; Singh R; Tuli HS
Pharm Pat Anal; 2021 Jan; 10(1):37-49. PubMed ID: 33445965
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hepatitis C virus replication in vitro by xanthohumol, a natural product present in hops.
Lou S; Zheng YM; Liu SL; Qiu J; Han Q; Li N; Zhu Q; Zhang P; Yang C; Liu Z
Planta Med; 2014 Feb; 80(2-3):171-6. PubMed ID: 24356905
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Application of Micellar Solubilized Xanthohumol in a Western-Type Diet-Induced Mouse Model of Obesity, Diabetes and Non-Alcoholic Fatty Liver Disease.
Mahli A; Seitz T; Freese K; Frank J; Weiskirchen R; Abdel-Tawab M; Behnam D; Hellerbrand C
Cells; 2019 Apr; 8(4):. PubMed ID: 30999670
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of bovine viral diarrhea virus in vitro by xanthohumol: comparisons with ribavirin and interferon-alpha and implications for the development of anti-hepatitis C virus agents.
Zhang N; Liu Z; Han Q; Chen J; Lou S; Qiu J; Zhang G
Eur J Pharm Sci; 2009 Nov; 38(4):332-40. PubMed ID: 19720145
[TBL] [Abstract][Full Text] [Related]
15. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
[TBL] [Abstract][Full Text] [Related]
16. Transmission of hepatitis C virus infection to tree shrews.
Xie ZC; Riezu-Boj JI; Lasarte JJ; Guillen J; Su JH; Civeira MP; Prieto J
Virology; 1998 May; 244(2):513-20. PubMed ID: 9601519
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes.
Nikolic D; Li Y; Chadwick LR; Pauli GF; van Breemen RB
J Mass Spectrom; 2005 Mar; 40(3):289-99. PubMed ID: 15712367
[TBL] [Abstract][Full Text] [Related]
18. Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice.
Nozawa H
Biochem Biophys Res Commun; 2005 Oct; 336(3):754-61. PubMed ID: 16140264
[TBL] [Abstract][Full Text] [Related]
19. Xanthohumol impairs autophagosome maturation through direct inhibition of valosin-containing protein.
Sasazawa Y; Kanagaki S; Tashiro E; Nogawa T; Muroi M; Kondoh Y; Osada H; Imoto M
ACS Chem Biol; 2012 May; 7(5):892-900. PubMed ID: 22360440
[TBL] [Abstract][Full Text] [Related]
20. Antigenotoxic effect of Xanthohumol in rat liver slices.
Plazar J; Filipic M; Groothuis GM
Toxicol In Vitro; 2008 Mar; 22(2):318-27. PubMed ID: 17981005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
